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Ethanol-induced neuro-developmental abnormalities are associated with impaired insulin and IGF signaling, and increased
oxidative stress in CNS neurons. We examined the roles of ethanol and its principal toxic metabolite, acetaldehyde, as mediators
of impaired insulin/IGF signaling and oxidative injury in immature cerebellar neurons. Cultures were exposed to 3.5mM
acetaldehyde or 50mM ethanol ± 4-methylpyrazole (4-MP), an inhibitor of ethanol metabolism, and viability, mitochondrial
function, oxidative stress, DNA damage, and insulin responsiveness were measured 48 hours later. Acetaldehyde or ethanol
increased neuronal death and levels of 8-OHdG and 4-HNE, and reduced mitochondrial function. Ethanol inhibited insulin
responsiveness, whereas acetaldehyde did not. 4-MP abated ethanol-induced oxidative stress and mitochondrial dysfunction,
but failed to restore insulin responsiveness. Furthermore, alcohol and aldehyde metabolizing enzyme genes were inhibited by
prenatal ethanol exposure; this eﬀect was mediated by acetaldehyde and not ethanol + 4MP. These ﬁndings suggest that brain
insulin resistance in prenatal alcohol exposure is caused by direct eﬀects of ethanol, whereas oxidative stress induced neuronal
injury is likely mediated by ethanol and its toxic metabolites. Moreover, the adverse eﬀects of prenatal ethanol exposure on brain
development may be exacerbated by down-regulation of genes needed for metabolism and detoxiﬁcation of alcohol in the brain.
1.Introduction
Prenatal alcohol exposure causes fetal alcohol spectrum
disorder (FASD), which is associated with multiple and
varied developmental abnormalities in the brain and results
in sustained deﬁcits in cognitive and motor functions [1–6].
Ethanol exerts its neurotoxic and teratogenic eﬀects [7, 8]
by promoting oxidative stress and impairing insulin and
insulin-like growth factor (IGF) signaling in the developing
brain [9, 10]. Whether these eﬀects are mediated by direct
toxic eﬀects of ethanol or its principal metabolite, acetalde-
hyde, has not yet been determined.
Ethanol has broad inhibitory eﬀects on insulin and
IGF signaling in the developing brain and immature neu-
rons. For example, ethanol impairs ligand-receptor bind-
ing, tyrosine phosphorylation and activation of receptor
tyrosine kinases, transmission of signals through insulin
receptorsubstrate(IRS)proteins,anddownstreamactivation
of phosphatidylinositol-3 kinase (PI3 kinase)-Akt, p21ras,
and mitogen-activated protein kinase kinase (MAPKK)
[11]. Consequences include reduced neuronal proliferation,
survival, migration, mitochondrial function, ATP produc-
tion, membrane integrity, plasticity, and neurotransmit-
ter function [10, 12–23]. Importantly, ethanol impairs
insulin/IGF signaling and impairs ligand-receptor binding
[17], and it activates phosphatases that negatively regu-
late receptor tyrosine kinases (PTP-1b) [24–26]. There-
fore, ethanol exposure causes major defects in insulin/
IGF signaling, beginning at the most proximal points
within the cascades, and eﬀectively results in a state of
chronic insulin/IGF resistance in developing CNS neu-
rons.2 Oxidative Medicine and Cellular Longevity
Ethanol also has cytotoxic eﬀects that are manifested by
increased oxidative stress and DNA damage. Ethanol toxicity
perturbsthestructuralandfunctional integrityofmitochon-
dria, particularly in liver and brain. Ethanol causes oxida-
tive modiﬁcation of mitochondrial DNA (MtDNA), man-
ifested by increased 8-hydroxydeoxyguanosine (8-OHdG)
incorporation, reduced MtDNA content, and increased
MtDNA single-strand breaks [12, 23, 27–30]. Ethanol-
induced MtDNAdamage and impaired Mt function increase
cellular sensitivity to toxins and promote Mt permeability
transition resulting in necrosis or apoptosis [12, 23, 29,
30]. These adverse eﬀects of ethanol are likely mediated by
increased oxygen free radical production, lipid peroxidation,
and inhibition ofMt glutathione.Ethanol metabolism by the
microsomal monoxygenase system, involving the alcohol-
inducible cytochrome P450 2E1 (CYP2E1), could contribute
to oxidative cellular injury through hydroxylethyl radical
formation [31, 32].
Alcohol is metabolized and detoxiﬁed by a series of
oxidation reactions, beginning with reversible oxidation of
ethanol to acetaldehyde by alcohol dehydrogenase (ADH),
CYP2E1, and catalase [33–35]. However, ADH, which has
ah i g ha ﬃnity for alcohol, is the main oxidizing enzyme
[36]. The cytosoliclocalizationofADHleads toacetaldehyde
formation and accumulation in the cytoplasm. CYP2E1 is
induced by chronic alcohol consumption and results in
acetaldehyde formation in peroxisomes. Catalase, which is
abundantly expressed in brain, oxidizes alcohol to acetalde-
hyde in microsomes [37, 38]. Acetaldehyde, which is highly
toxic, is irreversibly oxidized to acetate by mitochondrial
aldehyde dehydrogenase (ALDH) as well as CYP2E1, a
microsomal acetaldehyde-oxidizing system that utilizes an
NADPH-dependent pathway [39]. Activated acetate forms
acetyl CoA, which breaks down to form CO2 and H2O[ 40].
Acetaldehyde accumulates and exerts its toxic eﬀects
when the enzymatic pathways responsible for oxidizing
alcohol become overwhelmed. The electrophilic nature of
acetaldehyde [36, 41] renders it highly reactive, enabling it to
bind and form adducts, that is, covalent chemical additions,
with proteins, lipids, and DNA [35, 42–45]. Adducts are
pathogenic, because they impair functions of proteins and
lipids, promote DNA damage and mutation [35], and
increase the generation of reactive oxygen species (ROS)
[14], resulting in broad-ranging impairments in protein
function, gene expression, and DNA integrity, including
increased mutagenesis [35, 45–47]. Increased levels of ROS
canimpairneuronalviabilitybyinhibitingelectrontransport
c h a i nf u n c t i o na n dA T Pf o r m a t i o n[ 14, 48, 49].
2.Results
2.1. Acetaldehyde Impairs Neuronal Viability and Mitochon-
drial Function and Increases Oxidative Stress. Initial studies
characterized acetaldehyde dose eﬀects on neuronal viability
and mitochondrial function. Crystal violet staining was used
to measure viability, and the 3-(4,5-Dimethylthiazol-2-Yl)-
2,5-Diphenyltetrazolium Bromide (MTT) assay was used
to measure mitochondrial function. Acetaldehyde exposure
for 24hours had modest eﬀects on neuronal viability and
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Figure 1: Acetaldehyde treatment impairs neuronal viability and
mitochondrialfunction. Rat cerebellar neuron cultures were treated
with 0.045–23.0mM acetaldehyde for 48 hours. (a) Viability was
measured using the Crystal violet assay, and (b) mitochondrial
function was measured with the MTT assay. Graphs depict the
mean ± S.E.M. of results from 16 replicate 96-well cultures.
mitochondrial function (data not shown). However, after
48hours exposure, acetaldehyde resulted in dose-dependent
declines in both cell viability and mitochondrial function
(Figure 1). Subsequent experiments were conducted using
3.5mMacetaldehydetreatmentfor48hours.
Corresponding with the crystal violet assay results,
the CyQuant assay demonstrated signiﬁcantly reduced cell
viabilityinacetaldehyde-treatedcultures(Figure 2(c)).Mito-
Tracker dye studies and measurements of ATP content were
used to better characterize eﬀects of acetaldehyde treat-
ment on mitochondrial function. Acetaldehyde treatment
signiﬁcantly reduced MitoTracker Red (Figure 2(e)), but it
did not signiﬁcantly alter MitoTracker Green ﬂuorescence
(Figure 2(f)). In addition, ATP content was profoundly
reduced by the acetaldehyde treatment (Figure 2(d)).
Cellular enzyme-linked immunosorbent assays (ELISAs)
were used to measure immunoreactivity corresponding to
4-hydroxy-2-nonenal (4-HNE), 8-hydroxydeoxyguanosineOxidative Medicine and Cellular Longevity 3
(8-OHdG), choline acetyltransferase (ChAT), and glycer-
aldehyde-3-phosphate dehydrogenase (GAPDH). The acet-
aldehyde-induced reductions in cell viability and mitochon-
drial function were associated with signiﬁcantly increased
levels of 4-HNE (Figure 2(a)) and 8-OHdG (Figure 2(b))
immunoreactivity, reﬂecting increased lipid peroxidation
and DNA damage, respectively. In contrast, acetaldehyde
treatment did not signiﬁcantly alter ChAT or GAPDH
immunoreactivity Figures 2(g) and 2(h),b o t ho fw h i c ha r e
responsive to insulin and IGF-1 stimulation [50].
2.2.AcetaldehydeDoes NotImpair Neuronal Insulin Signaling.
In previous studies, we demonstrated that acute or chronic
exposure to ethanol leads to impaired insulin-stimulated
responses in CNS neuronal cells, resulting in signiﬁcant
inhibition of insulin-stimulated phosphorylation of ERK
MAPK and Akt [10]. To determine if these eﬀects could be
mediated by acetaldehyde, 96-well acetaldehyde (3.5mM)
or vehicle treated (48h) microcultures were stimulated
with 10nM insulin for up to 60minutes, after which they
were ﬁxed in situ and examined for immunoreactivity to
pERK, total ERK, pAkt, or total Akt by cellular ELISA.
Immunoreactivity was normalized to H33342 ﬂuorescence,
and relative increases in phosphorylation, that is, phos-
pho/total protein, were calculated for each time point. Eight
replicate assays were performed per time point, and the
experiments were repeated twice (Figure 3). The results
demonstrated higher levels of pERK, ERK, pAkt, and Akt
in acetaldehyde-treated relative to control at nearly all
time points (Figures 3(a)–3(d)). However, acetaldehyde and
vehicle-treated cells exhibited similar trends with regard to
t h et i m ec o u r s eo fi n s u l i n - s t i m u l a t e dp E R K( Figure 3(a))
and pAkt (Figure 3(b)), and curves deﬁning the calculated
phospho/total protein ratios were virtually identical for both
kinases (Figures 3(e) and 3(f)). This result contrasts with
the eﬀects of ethanol, which signiﬁcantly reduced insulin-
stimulated phospho- and phospho/total ERK and Akt levels
at all time points (Figure 4).
2.3. Chronic Prenatal Ethanol Exposure Alters Alcohol Metab-
olizing EnzymeGeneExpression in Brain. The in vitro experi-
mentsdemonstrate that acetaldehydeexposure has profound
inhibitory eﬀects on viability and mitochondrial function
and that it increases oxidative stress and DNA damage in
immature CNS neurons. To determine the potential role
of acetaldehyde-mediated neurotoxicity as a mediator of
neurodevelopmental defects in FASD, it was important to
characterize the expression proﬁles of genes that regulate
alcohol and acetaldehyde metabolism and determine the
eﬀects of ethanol exposure on the expression of these genes.
WeusedqRT-PCRanalysistomeasureexpressionofmultiple
isoforms of alcohol and acetaldehyde dehydrogenase, in
addition to CYP2E1 and catalase. Those initial studies
demonstratedthatADH1,ADH7,ALDH1,ALDH2,ALDH3,
CYP2E1, and catalase mRNA transcripts were detectable in
normal rat pup cerebella. Subsequent studies were narrowed
to examine eﬀects of chronic gestational exposure to ethanol
on the expression of these 7 genes.
The in vivo experimental models were generated by
feeding pregnant Long Evans rat dams with isocaloric liquid
diets that contained 0%, 18%, or 37% ethanol by caloric
content as previously described. Rat pups exposed to the
18% ethanol diet had moderate abnormalities in cerebellar
architecture,whilethoseexposedtothe37%ethanoldiethad
fetal alcohol syndrome with severe cerebellar hypoplasia and
pronounceddeﬁcitsinneuronalmigration[17,51].Thegene
expression studies demonstrated that chronic gestational
exposure to the 18% or 37% ethanol containing diets signif-
icantly reduced expression of ADH1, ALDH2, and catalase,
and signiﬁcantly increased expression of CYP2E1 (Figure 5).
In addition, exposure to the 37% diet signiﬁcantly reduced
ALDH1 expression, while exposure to the 18% ethanol
diet signiﬁcantly increased ALDH3 expression. Inhibition of
ADH and catalase would lead to increased local levels of
ethanol, whereas inhibition of ALDH and CYP2E1 would
result in increased local levels of acetaldehyde.
2.4. Ethanol’s Toxic Metabolites Cause Oxidative Stress and
Mitochondrial Dysfunction, but Not Insulin Resistance. We
next performed experiments to determine the degree to
which oxidative injury, DNA damage, mitochondrial dys-
function,andimpairedinsulinresponsivenessweremediated
by ethanol or its toxic metabolites. Neuronal cultures (96-
well) were exposed to 50mM ethanol for 96h and treated
with vehicle or 4-MP. The cultures were stimulated with
10nM insulin for the last 24h in culture. The ethanol-
exposed, vehicle-treated cells had signiﬁcantly higher levels
of 4-HNE (Figure 6(a)), 8-OHdG (Figure 6(b)), and Mito-
Tracker Green ﬂuorescence (Figure 6(f)), and reduced levels
of viability (Cyquant assay; Figure 6(c)), ATP production
(Figure 6(d)), and mitochondrial function (MitoTracker
Red ﬂuorescence; Figure 6(e)) relative to corresponding
controls. In addition, ChAT and GAPDH immunoreactivity
were signiﬁcantly reduced in the ethanol-treated cultures
(Figures 6(g) and 6(h)). Simultaneous treatment with 4-
MP signiﬁcantly reduced 4-HNE immunoreactivity in both
control and ethanol-exposed cultures. Otherwise, mito-
chondrial function, viability, and insulin-stimulated protein
expression were not signiﬁcantly changed by the 4-MP
treatments. In contrast, 4-MP treatment of ethanol-exposed
cultures signiﬁcantly reduced 8-OHdG immunoreactivity
and increased MitoTracker Red ﬂuorescence such that the
diﬀerencefromcontrol wasno longerstatistically signiﬁcant.
However, 4-MP treatment of ethanol-exposed cells did not
signiﬁcantly increase neuronal viability, ATP levels, or ChAT
and GAPDH immunoreactivity. Therefore, the main positive
eﬀects of inhibiting ethanol metabolism with 4-MP were
to reduce oxidative stress, DNA damage, and mitochondrial
dysfunction.
3.Discussion
In FASD, the main focus has been on the role of ethanol-
mediated neurotoxicity and the functional abnormalities
leading to impairments in neurodevelopment. In particular,
our studies have detailed the adverse eﬀects of ethanol on
insulin and IGF signaling mechanisms in the brain and CNS4 Oxidative Medicine and Cellular Longevity
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Figure 2: Acetaldehyde causes neuronal oxidative stress, DNA damage, and mitochondrial dysfunction. Rat cerebellar neuron cultures were
treated with 3.5mM acetaldehyde for 48 hours, and used to measure (a) 4-HNE, (b) 8-OHdG, (c) Cyquant ﬂuorescence-viability (CYQ),
(d) ATP content, (e) MitoTracker Red (MTR), (f) MitoTracker Green (MTG), (g) ChAT and (h) GAPDH. 4-HNE, 8-OHdG, ChAT, and
GAPDH immunoreactivities were measured by cellular ELISA. Viability and mitochondrial assays were measured in labeled cells. All results
were normalized to H33342 ﬂuorescence, which is linearly correlated with cell number. Box plots depict the mean (horizontal bar), 95%
conﬁdence interval limits (upper and lower edges of boxes), and range (whiskers). Inter-group comparisons were made using Student T-
tests. Signiﬁcantdiﬀerences are indicated within the panels.Oxidative Medicine and Cellular Longevity 5
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Figure 3: Acetaldehyde does not impair insulin stimulated signaling through ERK and Akt. Rat cerebellar neuron cultures seeded into 96-
well plates, were treated with 3.5mM acetaldehyde for 48 hours, and then stimulated with 10nM insulin for up to 60 minutes. Cells were
ﬁxed and used to measure (a) pERK, (b) pAkt, (c) total ERK, and (d) total Akt by cellular ELISA, and results were normalized to H33342
ﬂuorescence. The ratios of (e) pERK/total ERK and (f) pAkt/total Akt were calculated to show relative time-dependent shifts in insulin-
stimulated signaling. Graphs depict the mean ± S.E.M. of results generated from 8 replicate assays. These results are strikingly diﬀerent
from those obtained using ethanol-treated cultures (see Figure 4). Inter-group diﬀerences with respect to pERK, pAkt, ERK, and Akt are
statistically signiﬁcant by area-under-curve analysis. However, relative levels of ERK and Akt phosphorylation are similar for vehicle and
acetaldehyde-treated cultures.6 Oxidative Medicine and Cellular Longevity
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Figure 4: Ethanol impairs insulin-stimulated phosphorylation of ERK MAPK and Akt. Control and ethanol-exposed (50mM x 48h) rat
cerebellar neuron cultures, seeded into 96-well plates, were stimulated with 10nM insulin for up to 30 minutes. Cells were ﬁxed and used to
measure (a) pERK, (b) pAkt, (c) total ERK, and (d) total Akt by cellular ELISA, and results were normalized to H33342 ﬂuorescence. The
ratios of (e) pERK/total ERK and (f) pAkt/total Akt were calculated to show relative time-dependent shifts in insulin-stimulated signaling.
Graphsdepict themean±S.E.M.ofresultsgeneratedfrom8replicate assays.Inter-group diﬀerences withrespect topERK, pAkt,pERK/Total
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Figure 5: Eﬀects of prenatal ethanol exposure on expression of
alcohol metabolizing enzyme gene expression in cerebellar tissue.
Cerebella from postnatal day 2-3 rat pups from dams that had been
chronically fed with isocaloric liquid diets containing 0%, 18%, or
37% ethanol by caloric content were used to measure expression
of diﬀerent isoforms of (a) alcohol dehydrogenase (ADH) or (b)
aldehydedehydrogenase(ALDH),aswellascatalaseandCYP2E1by
qRT-PCR analysis.Results were normalized to 18S rRNA measured
in the same samples. Inter-group comparisons were made using
repeated measures ANOVA with the Dunnett post hoc test to detect
signiﬁcantdiﬀerences from control. ∗P<. 05; ∗∗∗P<. 01.
neuronal cells and demonstrated how impaired insulin/IGF
responsiveness correlated with decreased neuronal survival,
mitochondrial function, energy metabolism, migration, and
neurotransmitter function [11]. However, those studies con-
sistently correlated ethanol-associated neurodevelopmental
structural and functional CNS abnormalities with impair-
ments in trophic factor signaling, including insulin and IGF,
andincreasedlevelsofoxidativestress.Sinceinsulinsignaling
mediates metabolic functions, impaired insulin signaling
or insulin resistance could reduce energy metabolism and
promote oxidative stress. On the other hand, acetaldehyde,
a major toxic metabolite of ethanol, is a potent mediator
of oxidative stress due to ROS generation, increased lipid
peroxidation and DNA damage, and formation of adducts
that potentially could impair a broad array of cellular
functions [33]. Therefore, it was of interest to determine
the degree to which acetaldehyde accumulation is likely to
contribute to CNS neuronal abnormalities in FASD.
Initial studies demonstrated that acetaldehyde is neuro-
toxic toimmature cerebellar neurons and that it impairs both
viability and mitochondrial function in a dose-dependent
manner. The steep declines in viability and mitochondrial
function observed following exposure to 0.045 to 0.72mM
acetaldehyde point to the marked sensitivity of CNSneurons
to acetaldehyde, since previous studies demonstrated that
exposures up to 20mM or even 100mM acetaldehyde were
used to achieve cellular injury including DNA damage in
vitro [52, 53]. The more detailed studies of acetaldehyde
eﬀects on neuronal viability and function were conducted
with relatively low concentrations of acetaldehyde (3.5mM)
to avoid producing global severe injury that would cause
extensive neuronal cell death.
Using in vitro functional assays combined with cellular
ELISAs, we demonstrated that acetaldehyde treatment sig-
niﬁcantly increased 4-HNE and 8-OHdG immunoreactivity,
reﬂecting lipid peroxidation and DNA damage with adduct
formation in immature neuronal cells. Previous studies
demonstrated that these eﬀects are characteristic of acetalde-
hyde exposure in other cell types, including hepatocytes
[33]. Moreover, comparing the eﬀects of ethanol versus
ethanol + 4-MP treatment, it appears that acetaldehyde
ratherthanethanolmediatestheseeﬀectsinethanol-exposed
neuronal cells. In essence, accumulation of acetaldehyde
in the setting of CNS ethanol exposure and metabolism
may be largely responsible for the attendant lipid peroxi-
dation, permanent DNA damage, and generation of ROS.
In contrast, neuronal viability (CyQuant assay) and ATP
production were strikingly reduced by acetaldehyde and
ethanol ± 4-MP treatment, suggesting that these functions
are signiﬁcantly compromised by ethanol and its main toxic
metabolite, acetaldehyde. Importantly, inhibition of ethanol
oracetaldehydemetabolismcouldresultin higherlocallevels
of either one or both, and thereby could lead to reduced
neuronal viability and energy metabolism in immature CNS
neurons.
MitoTracker ﬂuorescent dye labeling studies were used
to examine eﬀects of acetaldehyde treatment on mito-
chondrial function (MitoTracker Red) and mitochondrial
mass (MitoTracker Green). Previous studies revealed that
ethanol impairs mitochondrial function in cerebellar neu-
rons [10–13, 54]. The present work conﬁrms that result and
demonstrates prominent inhibitory eﬀects of acetaldehyde
on mitochondrial function but with no signiﬁcant eﬀect on
mitochondrial mass. In addition, the studies demonstrated
that ethanol exposure results in increased mitochondrial
mass, which could serve to compensate for the impairments
in mitochondrial function caused by mitochondrial DNA
damage and inhibition of electron transport chain enzyme
activity. The ﬁnding that 4-MP increased the MitoTracker
Red ﬂuorescence in ethanol-exposed cultures supports the
notion that the mitochondrial dysfunction associated with
ethanol exposure is largely mediated by acetaldehyde gener-
ation and accumulation in neuronal cells.8 Oxidative Medicine and Cellular Longevity
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Figure 6: Eﬀects of 4-methylpyrazole (4-MP) treatment on ethanol-induced neurotoxicity. Control or ethanol exposed (50mM) rat
cerebellar neuron cultures seeded into 96-well plates were treated with vehicle or 4-MP for 48h. The cells were used to measure (a) 4-
HNE, (b) 8-OHdG, (c)Cyquant ﬂuorescence-viability (CYQ),(d) ATP content,(e) MitoTrackerRed (MTR),(f) MitoTrackerGreen (MTG),
(g) ChAT, and (h) GAPDH. 4-HNE, 8-OHdG, ChAT, and GAPDH immunoreactivities were measured by cellular ELISA. Viability and
mitochondrial assays were measured in labeled cells. All results were normalized to H33342 ﬂuorescence. Graphs depict the mean ± S.D. of
results. Statistical comparisons were made using two-way ANOVA with the post hoc Bonferroni signiﬁcance test. Signiﬁcant diﬀerences are
shownwithin each panel. ∗∗P<. 01 and ∗∗∗P<. 001 between control and ethanol-exposed cells within the vehicle- or 4-MP treated groups.Oxidative Medicine and Cellular Longevity 9
A major CNS abnormality associated with ethanol expo-
sure,bothduringdevelopmentandintheadultbrain,isneu-
ronalinsulinresistance[10,17,24,55–57],whichismediated
by impaired ligand-receptor binding, activation of receptor
tyrosine kinases, transmission of signals through IRS pro-
teins, and activation of downstream pathways that promote
neuronal survival, energy metabolism, plasticity, migration,
and neurotransmitter function [50]. Previous studies sug-
gested that oxidative stress can have either stimulatory
[58] or inhibitory [59, 60]e ﬀects on insulin/IGF signaling
through pathways that regulate cell migration, survival, and
energy metabolism. Therefore, it was of interest to determine
if acetaldehyde plays a role in dysregulating insulin signaling
in the CNS. Herein, we measured insulin-stimulated ERK
and Akt phosphorylation/activation in acetaldehyde-treated
or ethanol-treated cerebellar neuron cultures. The results
showed that acetaldehyde had no signiﬁcant eﬀect on the
time course or levels of Erk or Akt phosphorylation relative
to vehicle-treated cultures, whereas the ethanol treatments
signiﬁcantly impaired insulin-stimulated phosphorylation
of Erk MAPK and Akt. Correspondingly, acetaldehyde
treatment did not inhibit expression of ChAT and GAPDH
proteins, and ethanol inhibition of ChAT and GAPDH was
not prevented by 4-MP treatment. These results suggest
that the adverse eﬀects of ethanol leading to impairments
in cholinergic function and neuronal migration are more
likely due to inhibition of insulin/IGF signaling than the
generation or accumulation of acetaldehyde in the brain.
Ethanol impairs insulin signaling, in part by altering the
plasma membrane lipid composition, leading to reduced
ligand binding to receptors [17]. Although acetaldehyde
exposure could also compromise growth factor signaling
by forming adducts with cytoskeletal proteins and thereby
impairingreceptor-mediatedendocytosis[60],thedominant
eﬀectof acetaldehydeis to form stable adductswith proteins,
impairing their functions, and thereby promoting cell injury
[35].
Finally, it was of interest to determine if chronic ethanol
exposure itself renders thedevelopingbrainmore susceptible
to injury by alcohol or its metabolites. Gene expression
studies demonstrated that chronic gestational exposure to
ethanol inhibited ADH1, ALDH1, ALDH2, and catalase
but increased CYP2E1 expression. Inhibition of ADH and
catalase could result in higher local levels of ethanol, and
thereby contribute to the inhibitory eﬀects of ethanol on
insulin/IGF signaling in the brain. In addition, inhibition
of ALDH2 could promote acetaldehyde accumulation and
lead to increased oxidative injury, lipid peroxidation, DNA
damage, and ROS generation. The signiﬁcantly increased
levels of ALDH3 in the 18% ethanol group relative to
control suggest a possible compensatory response to the
inhibition of ALDH2. The greater impact of the higher
levels of chronic ethanol exposure could be attributed
in part to the simultaneous inhibition of ALDH1 and
relatively normal (nonelevated) levels of ALDH3. The
increased CYP2E1 expression observed in chronic ethanol-
exposed brains is consistent with previous data showing
that CYP2E1 is induced by chronic ethanol exposure [33].
However,consequencesofincreasedCYP2E1activity include
excess ROS production, leading to increased oxidative stress
and ROS-generated radicals including superoxide anion
and hydroxyethyl radicals. In addition, CYP2E1-generated
hydrogen peroxide in peroxisomes can react with metal ions
to produce hydroxyl radicals. The net result is increased
formation of adducts with lipids, proteins, and DNA, with
attendant failure of a broad range of biological systems.
4.Materialsand Methods
4.1. Materials. The bicinchoninic acid (BCA) kit to measure
protein concentration was purchased from Pierce Chemical
Co. (Rockford, Ill). Histochoice ﬁxative was purchased from
Amresco, Inc. (Solon, Ohio). Amplex UltraRed soluble
ﬂuorophore, MitoTracker Red, MitoTracker Green, H33342,
and CyQuant reagent were purchased from Invitrogen
(Carlsbad, Calif). Maxisorp 96-well plates used for ELISAs
were from Nunc (Thermo Fisher Scientiﬁc; Rochester, NY).
Superblock-TBS, and horseradish peroxidase conjugated
antibodies were from Pierce Chemical Co. (Rockford, Ill).
Antibodies to active [pS473]-Akt and [pT202+pY204]-
ERK1/ERK2 and total Akt and ERK MAPK were pur-
chased from Cell Signaling Technology (Danvers, Mass).
All other monoclonal antobodies and immunodetection
reagents used for enzyme-linked immunosorbent assays
(ELISAs) were purchased from Abcam (Cambridge, Mass),
Upstate (Billerica, Mass), Vector Laboratories (Burlingame,
Calif), Invitrogen (Carlsbad, Calif) or Chemicon (Temecula,
Calif). Fine chemicals were purchased from CalBiochem
(Carlsbad, Calif), or Sigma-Aldrich (St Louis, Mo). QIAzol
Lysis Reagent for RNA extraction and QuantiTect SYBR
Green PCR Mix were obtained from Qiagen, Inc. (Valencia,
Calif). The AMV 1st Strand cDNA Synthesis Kit was
purchased from Roche Applied Science (Indianapolis, Ind).
Synthetic oligonucleotides used in quantitative polymerase
chain reaction (qPCR) assays were purchased from Sigma-
Aldrich Co. (St. Louis, Mo). ATPLite reagents were pur-
chased from PerkinElmer (Boston, Mass).
4.2. In Vitro Models. Primary neuronal cultures were gen-
erated with postnatal day 8 rat pup cerebella [24, 61]
and maintained with Dulbecco’s modiﬁed Eagle’s medium
supplemented with 5% fetal calf serum, 4mM glutamine,
10mM nonessential amino acid mixture(Gibco-BRL,Grand
Island, NY), 25mM KCl, and 9g/L glucose. For ethanol
treatment, 6-well or 96-well cultures were placed in sealed
humidiﬁed chambers in which 50mM ethanol was supplied
to both the culture medium and reservoir tray [62]. Control
cultures were identically treated but with only water added
to the reservoir tray. The chambers were ﬂushed with gas
containing 75% nitrogen, 20% oxygen, and 5% carbon
dioxide, and the medium was changed daily with fresh
additions of ethanol to both the medium and reservoir
tray. Cultures were incubated in the chambers for up to
96hours at 37◦C. To measure responsiveness to growth
factor stimulation, the cells were serum-starved for 12hours
(starting after 48hrs in the chambers) and then stimulated
with 10nM insulin or vehicle in the chambers for 48hrs. To
determine the eﬀects of inhibiting ethanol metabolism on10 Oxidative Medicine and Cellular Longevity
viability, mitochondrial function, and gene expression, the
cultures were simultaneously treated with 4-methylpyrazole
(4-MP). To examine eﬀects of acetaldehyde exposure, 6-well
or 96-well cultures (not maintained in chambers or ethanol
exposed) were treated with up to 3.5mM acetaldehyde for
48h.
4.3. Cell Viability and Mitochondrial Studies. Cells seeded in
96 well plates were used to measure viability, mitochondrial
mass, and mitochondrial function. Cell viability was mea-
sured using the crystal violet assay [63], and mitochondrial
function was measured using the 3-(4,5-Dimethylthiazol-
2-Yl)-2,5-Diphenyltetrazolium Bromide (MTT) assay [13].
MitoTracker Green FM (Ex490/Em516), which labels mito-
chondria irrespective of oxidative activity, was used to mea-
sure mitochondrial mass. MitoTracker Red (CM-H2XRos;
Ex578/Em599), which accumulates in metabolically active
mitochondria and is rendered ﬂuorescent via oxidation
within the mitochondria, was used to measure mitochon-
drial function. Cultures were labeled with cell permeable
MitoTracker dyes for 15minutes at 37◦C according to the
manufacturer’s protocol, and ﬂuorescence light units (FLUs)
were measured with a Spectramax M5 microplate reader
(Molecular Dynamics, Inc. Sunnyvale, Calif) [13, 54, 64].
To assess cell density, the cells were subsequently stained
with Hoechst H33342 and ﬂuorescence was measured (Ex
360nm/Em 460nm) in a Spectramax M5 [54, 64]. Results
are expressed as MitoTracker/H33342ratioscalculatedfor 16
replicate cultures. ATP was measured using the ATPlite assay
according to the manufacturer’s protocol. Luminescence was
measured in a TopCount machine (Packard Instrument Co).
4.4. Cellular Enzyme-Linked Immunosorbent Assay (ELISA).
A cellular ELISA was used to measure immunoreactivity
directlyinculturedcells(96-wellplates)[65].Afterovernight
ﬁxation in Histoﬁx, cells were permeabilized with 0.05%
Tween 20 in Tris-buﬀered saline, pH7.5, then treated with
0.3% H2O2 in 60% methanol to quench endogenous per-
oxidase, and blocked with SuperBlock-TBS to adsorb non-
speciﬁc binding sites. Cells were incubated over night at 4◦C
with 0.5–1µg/mL primary antibody. Immunoreactivity was
detected with horseradish peroxidase conjugated Amplex
Red soluble ﬂuorophor, and ﬂuorescence intensity (Ex
530/Em 590) was measured in a Spectramax M5 microplate
reader (Molecular Dynamics, Inc., Sunnyvale, Calif). To
assess cell density, cells were then labeled with Hoechst
H33342 (Molecular Probes, Eugene, Ore) and ﬂuorescence
intensity (Ex360nm/Em460nm) was measured in the M5
Spectromax. Immunoreactivity was normalized to H33342
ﬂuorescence. At least 8 replicate cultures were analyzed in
each experiment. All experiments were repeated 3times.
4.5. In Vivo Ethanol Exposure Model. Pregnant Long-Evans
rats were pair-fed isocaloric liquid diets (BioServ, French-
town, NJ) containing 0%, 18%, or 37% ethanol by caloric
content, or 0%, 4.5%, or 9.25% v/v ethanol [12, 17]. The
liquid diets were begun on gestation day 6 and continued
until parturition. This approach was used, because earlier
periods of in utero ethanol exposure lead to excessive
fetal loss due to impaired placentation [66]. Rats were
monitored daily to ensure equivalent caloric consumption
and maintenance of body weight. Cerebella harvested on
postnatal days 2-3 were snap frozen in a dry ice-methanol
b a t ha n dt h e ns t o r e da t−80◦C for later extraction of RNA
to measure expression of alcohol metabolizing enzymes by
qRT-PCR analysis. Cerebellar tissue was studied, because
it represents a major target of ethanol neurotoxicity [2, 3,
24, 67, 68]. The Lifespan-Rhode Island Hospital IACUC
committee approved these procedures and the use of rats in
experiments.
4.6. RNA Studies. Total RNA was isolated from cultured
cells or cerebellar tissue using the EZ1 RNA Universal
Tissue Kit and the BIO Robot EZ1 (Qiagen Inc., Valen-
cia, Calif). RNA was reverse transcribed with random
oligonucleotide primers and the AMV First Strand cDNA
synthesis kit, and the resulting cDNAs were used to mea-
sure gene expression by qPCR with gene-speciﬁc primer
pairs (Supplementary Table 1 which could be found at
doi: 10.1155/2011/213286). Primers were designed using
MacVector 10 software (MacVector, Inc., Cary, NC), and tar-
get speciﬁcity was veriﬁed using NCBI-BLAST (Basic Local
Alignment Search Tool). The Master ep realplex instrument
and software (Eppendorf AG, Hamburg, Germany) were
used to detect ampliﬁed signals from triplicate reactions.
Relative mRNA abundance was calculated from the ng ratios
of mRNA to 18S rRNA measured in the same samples, and
those data were used for intergroup comparisons. Control
studies included analysis of (1) template-free reactions, (2)
RNAthat had not beenreversetranscribed, (3)RNAsamples
pretreated with DNAse I, (4) samples treated with RNAse A
prior to the reverse transcriptase reaction, and (5) genomic
DNA.
4.7. Statistical Analyses. Data depicted in bar graphs repre-
sent the means ± SEMs for each group. Data depicted in
box plots reﬂect the median horizontal bar), 95% conﬁdence
interval limits (upper and lower boundaries of boxes), and
range (whiskers). Intergroup comparisons were made using
one- or two-way analysis of variance (ANOVA) with the
Bonferroni post hoc test for signiﬁcance. Ethanol dose-
related trends were calculated by nonparametric linear
regression analysis. Statistical analyses were performed using
GraphPad Prism 5 software (GraphPad Software, Inc., San
Diego, Calif). Signiﬁcant P values (P<. 05 or better) are
indicated within the graph panels.
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